Becton, Dickinson and Company BDX
Verdict: Sell. Fair value $152 against a price of $199 on 5 Jan 2026, 24% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Extremely consistent earnings beats (0.0% to 0.1% surprise) over recent quarters suggest potential.... Large and persistent divergence between Net Income ($1.68B) and OCF ($3.43B) indicates heavy....
Main risks
- Declining GAAP Net Income (-5.6% vs 2022) despite 15% cumulative revenue growth, indicating margin compression.
- High leverage with Net Debt/EBITDA > 5.5x (based on proxy EBITDA), limiting financial flexibility.
- Extremely poor ROIIC (~2.1%) suggests recent capital investments are not generating sufficient incremental GAAP operating profit.
- Large and persistent divergence between Net Income ($1.68B) and OCF ($3.43B) indicates heavy...
- Valuation prices in optimistic scenario (limited margin for error)
- Large and persistent divergence between Net Income ($1.68B) and OCF ($3.43B) indicates heavy reliance on non-cash charges (likely amortization/impairments) which depresses GAAP earnings relative to cash generation.